Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guimin Su
Institution:
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd. (China)
Observed institution:
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd. (China)
ORCID:
0009-0008-4040-468X
Observed ORCID:
0009-0008-4040-468X
OpenAlex ID:
A5111299165
Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics
2024
·
Man Cui
, Xiaohui Ji
, et al.
·
Frontiers in Immunology
·
28
PDF
From pathogenesis to antigens: the key to shaping the future of TB vaccines
2024
·
Haoyan Yang
, Xinkui Lei
, et al.
·
Frontiers in Immunology
·
16
PDF
Candidate Antigens and the Development of Helicobacter pylori Vaccines
2024
·
Zhanhua Zhang
, Man Cui
, et al.
·
Helicobacter
·
15
A multi-epitope vaccine incorporating adhesin-derived antigens protects against Mycobacterium tuberculosis infection and dissemination
2025
·
Haoyan Yang
, Xinkui Lei
, et al.
·
Frontiers in Immunology
·
4
PDF
Stopping Tuberculosis at the Gate: The Role of M. tuberculosis Adhesins in Infection and Intervention
2025
·
Haoyan Yang
, Yinuo Ma
, et al.
·
Vaccines
·
4
PDF
Research advances of the establishment and characterization of Helicobacter pylori infection animal models
2025
·
Kaifang Zhang
, Man Cui
, et al.
·
Frontiers in Microbiology
·
2
PDF
Show more works
View as search
Works count:
6
Citation count:
69
H-index:
4
I10-index:
3
Year
Topic
Type